Review of Challenges in Performing Real-World Evidence Studies for Nonprescription Products
{{output}}
In recent years, regulatory authorities have signaled a willingness to consider real-world evidence (RWE) data to support applications for new claims and indications for pharmaceuticals. Historically, RWE studies have been the domain of prescription drugs, dri... ...
